{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:30:56Z","timestamp":1773433856148,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the Capital Characteristic Clinical Application Research Project of Beijing Municipal Science and Technology Plan of China","award":["Z181100001718153"],"award-info":[{"award-number":["Z181100001718153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s40744-021-00341-9","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T12:02:47Z","timestamp":1626955367000},"page":"1451-1462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic Effects of Ba-Duan-Jin versus Pregabalin for Fibromyalgia Treatment: Protocol for a Randomized Controlled Trial"],"prefix":"10.1007","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct03797560","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ruo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-7848","authenticated-orcid":false,"given":"Quan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"341_CR1","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"341_CR2","doi-asserted-by":"publisher","first-page":"E217","DOI":"10.36076\/ppj.2011\/14\/E217","volume":"14","author":"HS Smith","year":"2011","unstructured":"Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14(2):E217\u201345.","journal-title":"Pain Physician"},{"issue":"4","key":"341_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11916-016-0556-x","volume":"20","author":"S Chinn","year":"2016","unstructured":"Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016;20(4):25.","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"341_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356\u201363.","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"2","key":"341_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1300\/J094v14n02_02","volume":"14","author":"RA Scudds","year":"2016","unstructured":"Scudds RA, Li EKM, Scudds RJ. The prevalence of fibromyalgia syndrome in Chinese people in Hong Kong. J Musculoskelet Pain. 2016;14(2):3\u201311.","journal-title":"J Musculoskelet Pain"},{"key":"341_CR6","first-page":"678","volume":"8","author":"L Lin","year":"2007","unstructured":"Lin L, Xiao Z, Lin SF, Chen R, Lin RR, et al. A rural population survey of soft tissue rheumatic pain in Shantou, China. Shanxi Med J. 2007;8:678\u201380.","journal-title":"Shanxi Med J"},{"key":"341_CR7","first-page":"597","volume":"8","author":"CH Zang","year":"2007","unstructured":"Zang CH, Zeng QY, Li XF, Dong HY, Zhang AL. Epidemiological study of rheumatic diseases in Taiyuan area. Chin Remedies Clin. 2007;8:597\u2013602.","journal-title":"Chin Remedies Clin"},{"issue":"9","key":"341_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138492","volume":"10","author":"SY Zeng","year":"2015","unstructured":"Zeng SY, Gong Y, Zhang YP, et al. Changes in the Prevalence of rheumatic diseases in Shantou, China, in the past three decades: a COPCORD Study. PLoS ONE. 2015;10(9): e0138492.","journal-title":"PLoS ONE"},{"key":"341_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/DHPS.S95535","volume":"8","author":"S Bhusal","year":"2016","unstructured":"Bhusal S, Diomampo S, Magrey MN. Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc Patient Saf. 2016;8:13\u201323.","journal-title":"Drug Healthc Patient Saf"},{"issue":"8","key":"341_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/03007995.2018.1450743","volume":"34","author":"LM Arnold","year":"2018","unstructured":"Arnold LM, Choy E, Clauw DJ, et al. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin. 2018;34(8):1397\u2013409.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"341_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-016-0106-4","volume":"14","author":"LM Arnold","year":"2016","unstructured":"Arnold LM, Schikler KN, Bateman L, et al. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol. 2016;14(1):46.","journal-title":"Pediatr Rheumatol"},{"key":"341_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011790.pub2","author":"S Derry","year":"2016","unstructured":"Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD011790.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"341_CR13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.1208e35","volume":"69","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL. Multidisciplinary care and stepwise treatment for fibromyalgia. J Clin Psychiatry. 2008;69(12): e35.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"341_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","volume":"68","author":"RA Moore","year":"2013","unstructured":"Moore RA, Straube S, Aldington D. Pain measures and cut-offs\u2014\u2019no worse than mild pain\u2019 as a simple, universal outcome. Anaesthesia. 2013;68(4):400\u201312.","journal-title":"Anaesthesia"},{"issue":"4","key":"341_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo A, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol (English Edition). 2017;57(4):356\u201363.","journal-title":"Rev Bras Reumatol (English Edition)"},{"issue":"8","key":"341_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa0912611","volume":"363","author":"C Wang","year":"2010","unstructured":"Wang C, Schmid CH, Rones R, et al. A randomized trial of Tai Chi for fibromyalgia. New Engl J Med. 2010;363(8):743\u201354.","journal-title":"New Engl J Med"},{"key":"341_CR17","doi-asserted-by":"publisher","first-page":"k851","DOI":"10.1136\/bmj.k851","volume":"360","author":"C Wang","year":"2018","unstructured":"Wang C, Schmid CH, Fielding RA, et al. Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. BMJ. 2018;360:k851.","journal-title":"BMJ"},{"issue":"6","key":"341_CR18","first-page":"953","volume":"37","author":"J Jiao","year":"2019","unstructured":"Jiao J, Russell IJ, Wang W, Wang J, Zhao YY, Jiang Q. Ba-Duan-Jin alleviates pain and fibromyalgia-related symptoms in patients with fibromyalgia: results of a randomised controlled trial. Clin Exp Rheumatol. 2019;37(6):953\u201362.","journal-title":"Clin Exp Rheumatol"},{"issue":"07","key":"341_CR19","first-page":"600","volume":"50","author":"HXJ Cao","year":"2009","unstructured":"Cao HXJ, Liu J. Application of visual analogue scales in assessment of symptomatic outcome data. J Trad Chin Med. 2009;50(07):600\u20132.","journal-title":"J Trad Chin Med"},{"issue":"4","key":"341_CR20","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.","journal-title":"Arthritis Res Ther"},{"key":"341_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1478-7954-7-18","volume":"7","author":"JM Lin","year":"2009","unstructured":"Lin JM, Brimmer DJ, Maloney EM, Nyarko E, Belue R, Reeves WC. Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr. 2009;7:18.","journal-title":"Popul Health Metr"},{"issue":"10","key":"341_CR22","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00520-011-1357-8","volume":"20","author":"J Tian","year":"2012","unstructured":"Tian J, Hong JS. Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer. Support Care Cancer. 2012;20(10):2379\u201383.","journal-title":"Support Care Cancer"},{"issue":"6","key":"341_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5664\/jcsm.27351","volume":"4","author":"DJ Buysse","year":"2008","unstructured":"Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical\/polysomnographic measures in a community sample. J Clin Sleep Med. 2008;4(6):563\u201371.","journal-title":"J Clin Sleep Med"},{"key":"341_CR24","unstructured":"Liu XC, Tang M, Hu L, et al. Reliability and validity of the Pittsburgh sleep quality index. Chin J Psychiatry. 1996;29:103\u20137."},{"issue":"2","key":"341_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/0278-6133.20.2.112","volume":"20","author":"RC Arnau","year":"2001","unstructured":"Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol. 2001;20(2):2\u2013119.","journal-title":"Health Psychol"},{"issue":"6","key":"341_CR26","first-page":"762","volume":"20","author":"WH Yang","year":"2012","unstructured":"Yang WH, Wu D, Peng F. Application of Chinese version of Beck Depression Inventory II to Chinese first-year college students. Chin J Clin Psychol. 2012;20(6):762\u20134.","journal-title":"Chin J Clin Psychol"},{"issue":"1","key":"341_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/S1138741600006004","volume":"9","author":"E Remor","year":"2006","unstructured":"Remor E. Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS). Span J Psychol. 2006;9(1):86\u201393.","journal-title":"Span J Psychol"},{"key":"341_CR28","first-page":"11","volume":"9","author":"TZ Yang","year":"2003","unstructured":"Yang TZ, Huang HT. A epidemiological study on stress among urban residents in social transition period. Chin J Epidemiol. 2003;9:11\u20135.","journal-title":"Chin J Epidemiol"},{"issue":"1\u20132","key":"341_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","volume":"113","author":"RH Dworkin","year":"2005","unstructured":"Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1\u20132):9\u201319.","journal-title":"Pain"},{"issue":"4","key":"341_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1526-4637.2003.03040.x","volume":"4","author":"TE Elliott","year":"2003","unstructured":"Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003;4(4):331\u20139.","journal-title":"Pain Med"},{"key":"341_CR31","first-page":"38","volume":"2","author":"L Li","year":"2002","unstructured":"Li L, Wang H, Shen Y. Development and psychometric tests of a Chinese Version of the SF-36 Health Survey Scales. Chin J Prevent Med. 2002;2:38\u201342.","journal-title":"Chin J Prevent Med"},{"issue":"9","key":"341_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203755","volume":"13","author":"F Wolfe","year":"2018","unstructured":"Wolfe F, Walitt B, Perrot S, Rasker JJ, H\u00e4user W. Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS ONE. 2018;13(9): e0203755.","journal-title":"PLoS ONE"},{"issue":"12","key":"341_CR33","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3899\/jrheum.110569","volume":"38","author":"L Pauer","year":"2011","unstructured":"Pauer L, Winkelmann A, Arsenault P, et al. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol. 2011;38(12):2643\u201352.","journal-title":"J Rheumatol"},{"issue":"3","key":"341_CR34","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.jpain.2017.12.185","volume":"19","author":"L Pauer","year":"2018","unstructured":"Pauer L, Zhang F, Zhang X, Xu H, Zhang Z, Li Y. Baseline characteristics and pain response to pregabalin in a population of Chinese patients with fibromyalgia. J Pain. 2018;19(3):S78\u20139.","journal-title":"J Pain"},{"issue":"9","key":"341_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9(9):792\u2013805.","journal-title":"J Pain"},{"issue":"5","key":"341_CR36","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/ar4056","volume":"14","author":"H Ohta","year":"2012","unstructured":"Ohta H, Oka H, Usui C, Ohkura M, Suzuki M, Nishioka K. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Res Ther. 2012;14(5):R217.","journal-title":"Arthritis Res Ther"},{"key":"341_CR37","first-page":"419","volume":"7","author":"K Srivastava","year":"2013","unstructured":"Srivastava K, Arora A, Kataria A, Cappelleri JC, Sadosky A, Peterson AM. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence. 2013;7:419\u201334.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"341_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/acr.22111","volume":"66","author":"K Nasser","year":"2014","unstructured":"Nasser K, Kivitz AJ, Maricic MJ, Silver DS, Silverman SL. Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safety. Arthritis Care Res (Hoboken). 2014;66(2):293\u2013300.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00341-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T08:16:54Z","timestamp":1629620214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00341-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00341-9","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}